| Temperature-sensitive miR-483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells |
Jeff_Che |
May 11, 2016 4:19:25 AM |
| CHO microRNA engineering is growing up: Recent successes and future challenges |
Jeff_Che |
May 11, 2016 4:06:02 AM |
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells |
Jeff_Che |
May 11, 2016 3:57:28 AM |
| Buffeted by headwinds, Bavarian Nordic cancels IPO | FierceBiotech |
Jeff_Che |
May 6, 2016 9:18:52 AM |
| After ditching its IPO, Bavarian Nordic gains private placing | FierceBiotech |
Jeff_Che |
May 6, 2016 9:18:48 AM |
| Monday Morning |
Jeff_Che |
May 6, 2016 8:59:17 AM |
| Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer |
m_gaddis |
May 6, 2016 6:48:28 AM |
| The global burden of cancer: priorities for prevention |
m_gaddis |
May 6, 2016 6:43:30 AM |
| FDA APPROVES IMLYGICTM (TALIMOGENE LAHERPAREPVEC) AS FIRST ONCOLYTIC VIRAL THERAPY IN THE US |
m_gaddis |
May 6, 2016 6:41:19 AM |
| Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors |
m_gaddis |
May 6, 2016 6:35:37 AM |
